Found 5 matching trials
A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects
PHASE1PreTerm Labor (prior to 37 weeks gestation) is the largest single cause of ...
Location
GSK Investigational Site
A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour
PHASE3The primary objective of this study is to demonstrate the superiority of re...
Location
GSK Investigational Site
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Retosiban (GSK221149) When Dosed With Efavirenz (EFZ)
PHASE1This will be a randomized single sequence open label study. This study is d...
Location
GSK Investigational Site
A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
PHASE3The study's primary objective is to demonstrate the superiority of retosiba...
Location
GSK Investigational Site
A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With Ketoconazole
PHASE1This is a two part study. Part A of the study will evaluate the metabolites...
Location
GSK Investigational Site